- This line was added.
- This line was removed.
- Formatting was changed.
Problem and Target Outcome
The complexity of cancer care increases with each year with new drug regimens and tumor genomicscontinues to increase, with new drugs approved and biomarkers discovered each year. Oncologists need decision support with access to up-to-date, evidence-based information to provide the best care for patients. This combined with rising healthcare costs associated with expensive cancer therapies has led to the rapid growth uptake in use of oncology clinical pathways. , though it is cumbersome to maintain and share the pathways.
mCODE and other clinical or administrative data from the EHR provide input to mCODE enabled, computable oncology clinical pathways that are aligned with the HL7 FHIR Clinical Guidelines and mCODE implementation guides.
Standards based pathway definitions enable automated maintenance as well as sharing of definitions across institutions.
An Oncology Clinical Pathway (OCP): detailed decision tree protocol for selection of treatment options by oncologists, primarily focused on anticancer drug regimens for specific patient populations, including type, stage, and molecular subtype of disease.
Oncologist launches pathway Smart-on-FHIR application.
The oncologist accepts the treatment recommendation
Pathways contain oncology and other clinical data elements that are not in mCODE for branch navigation. These need to be modeled into CodeX elements to be used in pathway navigation.
This use case covers the use of the pathways application to reach a treatment option. Prior authorization is out of scope.
Conference Call Information
|First demo of Camino to UPenn||22 January 2020|
|First demo of Camino to UCSF||30 January 2020|